By vgreene, 27 January, 2020 If statin1 required due to risk base intensity on cholesterol level pt preference etc
By vgreene, 27 January, 2020 Mod intensity 30 49 LDL C lowering atorvastatin 10 or 20 mg rosuvastatin 5 or 10 mg simvastatin 20 40 mg pravastatin 40 or 80 mg lovastatin 40 or 80 mg fluvastatin XL 80 mg fluvastatin 40 mg bid pitavastatin 1 4 mg
By vgreene, 27 January, 2020 High intensity 50 LDL C lowering atorvastatin 40 or 80 mg rosuvastatin 20 or 40 mg
By vgreene, 27 January, 2020 If fhx is concerning or ↑Lp(a): Consider statins in context of informed, shared decision-making/counseling
By vgreene, 27 January, 2020 If metabolic syndrome 3 of these uarr waist circ TG 150 mg dL uarr BP uarr glucose HDL
By vgreene, 27 January, 2020 Estimate lifetime risk calc 1 risks 1 risk enhancing factors1 to determine primary prevention approach AACE specifies target LDL C based on risk 2 Heart healthy lifestyle 1 2 consider statin in select pts No RCT data available on CAC for this age group Pe
By vgreene, 27 January, 2020 5%-7.4% (borderline): Presence of risk enhancersRE favor mod-intensity statins. If statin decision uncertain, consider CACCC in select pts (eg, 40-55 yo)